133 related articles for article (PubMed ID: 6697813)
1. Combination of anticancer agents with folic acid in the treatment of murine leukaemia P388.
Parchure M; Ambaye RY; Gokhale SV
Chemotherapy; 1984; 30(2):119-24. PubMed ID: 6697813
[TBL] [Abstract][Full Text] [Related]
2. [Effects of combination chemotherapy of MCNU with various anti-cancer agents].
Machida S; Ito Y; Hoshino A
Gan To Kagaku Ryoho; 1985 Feb; 12(2):298-302. PubMed ID: 3918506
[TBL] [Abstract][Full Text] [Related]
3. Potentiation of vincristine by vitamin A against drug-resistant mouse leukaemia cells.
Nogae I; Kikuchi J; Yamaguchi T; Nakagawa M; Shiraishi N; Kuwano M
Br J Cancer; 1987 Sep; 56(3):267-72. PubMed ID: 3663474
[TBL] [Abstract][Full Text] [Related]
4. Combination chemotherapy of early and advanced murine P388 leukaemia with bouvardin, cis-diamminedichloroplatinum and vincristine.
Adwankar MK; Khandalekar DD; Chitnis MP
Oncology; 1984; 41(5):370-3. PubMed ID: 6540853
[TBL] [Abstract][Full Text] [Related]
5. Potentiation by vitamin A of the action of anticancer agents against murine tumors.
Nakagawa M; Yamaguchi T; Ueda H; Shiraishi N; Komiyama S; Akiyama S; Ogata J; Kuwano M
Jpn J Cancer Res; 1985 Sep; 76(9):887-94. PubMed ID: 3932288
[TBL] [Abstract][Full Text] [Related]
6. [Experimental combination chemotherapy of YNK01, a novel analog of cytarabine, with other antitumor agents].
Uchida T; Nagahata T; Arakawa M; Ekimoto H; Takahashi K
Gan To Kagaku Ryoho; 1990 Jul; 17(7):1351-6. PubMed ID: 2114829
[TBL] [Abstract][Full Text] [Related]
7. Enhancement of antitumour activity of etoposide by dihydropyridines on drug-sensitive and drug-resistant leukaemia in mice.
Kiue A; Sano T; Naito A; Okumura M; Kohno K; Kuwano M
Br J Cancer; 1991 Aug; 64(2):221-6. PubMed ID: 1892749
[TBL] [Abstract][Full Text] [Related]
8. Cure of mice bearing P388 leukemia by vincristine in combination with a calcium channel blocker.
Tsuruo T; Iida H; Tsukagoshi S; Sakurai Y
Cancer Treat Rep; 1985 May; 69(5):523-5. PubMed ID: 4005874
[TBL] [Abstract][Full Text] [Related]
9. Therapeutic synergism of tiazofurin and selected antitumor drugs against sensitive and resistant P388 leukemia in mice.
Harrison SD; O'Dwyer PJ; Trader MW
Cancer Res; 1986 Jul; 46(7):3396-400. PubMed ID: 3708573
[TBL] [Abstract][Full Text] [Related]
10. Combined effects of bromovinyldeoxyuridine and fractionated or continuous administration of 5-fluorouracil in P388 leukemia-bearing mice.
Keizer HJ; Pauwels R; Landuyt W; Balzarini J; van der Schueren E; De Clercq E
Cancer Lett; 1988 Mar; 39(2):217-23. PubMed ID: 3359416
[TBL] [Abstract][Full Text] [Related]
11. In vivo circumvention of vincristine resistance in mice with P388 leukemia using a novel compound, AHC-52.
Shinoda H; Inaba M; Tsuruo T
Cancer Res; 1989 Apr; 49(7):1722-6. PubMed ID: 2924316
[TBL] [Abstract][Full Text] [Related]
12. Comparative study of in vivo development of resistance to various classes of antitumor agents in P388 leukemia.
Inaba M; Fujikura R; Sakurai Y
Gan; 1979 Oct; 70(5):607-13. PubMed ID: 520752
[No Abstract] [Full Text] [Related]
13. Experimental combination chemotherapy of pirarubicin with various antitumor drugs against P388 murine leukemia.
Izumi H; Hirano S; Matsushita Y; Iguchi H; Tone H; Takeuchi T
Cancer Biochem Biophys; 1994 Sep; 14(2):137-49. PubMed ID: 7889494
[TBL] [Abstract][Full Text] [Related]
14. Therapeutic synergy of trimetrexate (CI-898) in combination with doxorubicin, vincristine, cytoxan, 6-thioguanine, cisplatin, or 5-fluorouracil against intraperitoneally implanted P388 leukemia.
Leopold WR; Dykes DJ; Griswold DP
NCI Monogr; 1987; (5):99-104. PubMed ID: 2963231
[TBL] [Abstract][Full Text] [Related]
15. [Combined effect of CDDP with various types of antitumor drugs against P 388 leukemia].
Uchida T; Nishikawa K; Shibasaki C; Okamoto K; Arakawa M; Ekimoto H; Takahashi K
Gan To Kagaku Ryoho; 1989 Jun; 16(6):2275-82. PubMed ID: 2735770
[TBL] [Abstract][Full Text] [Related]
16. Stability of the in vivo P388 leukemia model in evaluation of antitumor activity of natural products.
Marsh JC; Shoemaker RH; Suffness M
Cancer Treat Rep; 1985 Jun; 69(6):683-5. PubMed ID: 4016772
[TBL] [Abstract][Full Text] [Related]
17. Reversal by two dihydropyridine compounds of resistance to multiple anticancer agents in mouse P388 leukemia in vivo and in vitro.
Kiue A; Sano T; Naito A; Inada H; Suzuki K; Okumura M; Kikuchi J; Sato S; Takano H; Kohno K
Jpn J Cancer Res; 1990 Oct; 81(10):1057-64. PubMed ID: 1977728
[TBL] [Abstract][Full Text] [Related]
18. L-histidinol improves the selectivity and efficacy of alkylating agents and daunomycin in mice with P388 leukaemia.
Warrington RC; Fang WD
Br J Cancer; 1989 Nov; 60(5):652-6. PubMed ID: 2803940
[TBL] [Abstract][Full Text] [Related]
19. Effect of combined use of anticancer drugs with a polysaccharide preparation, Krestin, on mouse leukemia P388.
Oh-hashi F; Kataoka T; Tsukagoshi S
Gan; 1978 Apr; 69(2):255-7. PubMed ID: 680463
[TBL] [Abstract][Full Text] [Related]
20. Reversal of resistance to vincristine in P388 leukemia by various polycyclic clinical drugs, with a special emphasis on quinacrine.
Inaba M; Maruyama E
Cancer Res; 1988 Apr; 48(8):2064-7. PubMed ID: 3349478
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]